AARDVARK THERAPEUTICS INC (AARD) Stock Earnings & Estimates
NASDAQ:AARD - US0029421007 - Common Stock
8.3 USD
-0.19 (-2.24%)
8.3 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 1,988.89% | ||||
| EBITDA YoY % growth | -10.253M | -7.318M 28.63% | -22.769M -211.14% | N/A -126.79% | N/A -35.36% | N/A -44.29% | |
| EBIT YoY % growth | -10.363M | -7.415M 28.45% | -22.785M -207.28% | N/A -152.69% | N/A -34.04% | N/A 96.70% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 3.08% | N/A -7.92% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.75 | -0.80 | -0.85 -19.24% | -0.95 -43.73% | -0.88 -17.41% | -0.98 -22.29% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.272M -239.27% | -18.87M -99.68% | -19.38M -85.10% | -21.42M -33.19% | -19.89M -15.16% | -21.93M -16.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.66 | -0.61 | -0.05 | -7.84% |
| Q1 2025 Q2Q % growth | -0.71 | -0.69 | -0.02 | -3.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.88% | -3.84% | -10.17% |
| Revenue | N/A | N/A | N/A | N/A |